WVF Ag Consulting
Biological products fail to scale when science, sales, and regulatory are misaligned.
Selling biologicals requires a different playbook.
I help agricultural biological companies turn complex microbial science into focused commercialization strategies that actually gain traction.
Ag biologicals require a different commercialization strategy than traditional chemistry.
Their performance is highly dependent on environment, crop system, and application context. Companies that try to launch too broadly often create misalignment between product claims, field performance, and sales expectations, limiting adoption long before the technology reaches its full potential.
If your biological revenue is flat…
If your internal tension is rising…
If launch timelines keep stretching…
If your runway is running out…
I want to work with you.
Small to mid-sized biological companies.
Chemistry companies building biological portfolios.
Directors of Sales struggling with biological adoption.
R&D leaders preparing for launch.
Teams relaunching underperforming products.
The Three Pillars Framework
Most companies overinvest in one pillar and neglect the others.
I use a structured framework called the Three Pillars of Product Development to uncover which pillar is shorter than the others, because if any one pillar is weak, the product wobbles.
This framework was born from 15 years of industry experience where I implemented this framework myself. It’s how I designed my product development projects. By making sure that every task, experiment, or demo checks at least 2 of three pillars (ideally 3 of 3), you ensure that every dollar you spend bringing a product to market is working for you 3-fold.
I am a scientific-commercial translator.
With 15 years in microbial product development in multinational corporations to startups, I’ve launched biological products across crop and livestock systems.
I help companies:
Align R&D, regulatory, and commercial teams
Translate complex science into sales-ready language
Design product development with commercialization in mind
Train sales teams to confidently sell differentiated products
Identify and fix the “short leg” in your product strategy
Narrow go-to-market strategy for real traction
My work sits at the intersection of science and sales.
Because that’s where biological products either succeed or stall.
Results You can Expect
When the science-to-sales is in alignment, you can expect:
Sales confidence increases.
Messaging sharpens and hits home.
Regulatory stops being a hurdle and starts being an asset.
Data becomes usable and accessible.
Launches are focused.
Conversion improves.
Products dominate niches instead of diluting within crowded markets.
Biology is complex. Selling doesn’t have to be.
Ready to strengthen your product’s foundation?
Let’s identify the short pillar - and fix it.